In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...
The Central Drugs Standard Control Organisation (CDSCO) has launched a new risk classification module on the drug regulator's online system for medical devices in order to simplify the regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback